Hypercholesterolemia
Pro Research Analysisby 
Searched over 200M research papers for "hypercholesterolemia"
Hypercholesterolemia Overview and Health Risks
Hypercholesterolemia is a condition marked by very high levels of cholesterol in the blood. Cholesterol is essential for building cell membranes, making hormones, and aiding fat digestion, but excessive cholesterol increases the risk of heart disease and atherosclerotic cardiovascular disease (ASCVD) 13. This risk is especially pronounced in individuals with familial hypercholesterolemia (FH), a genetic form of the disorder 37.
Types and Classification of Hypercholesterolemia
There is no universally accepted diagnostic definition for hypercholesterolemia and its subtypes, which can lead to confusion in clinical practice. Recent efforts propose a unified, mechanism-based classification to help guide diagnosis and patient management without disrupting current ASCVD risk reduction strategies . Hypercholesterolemia can be classified as either primary (genetic or polygenic) or secondary (due to other causes), with familial hypercholesterolemia being the most recognized genetic form 245.
Familial Hypercholesterolemia: Genetics and Prevalence
Familial hypercholesterolemia is an inherited disorder that results in very high cholesterol levels, particularly low-density lipoprotein cholesterol (LDL-C). The most common genetic causes are mutations in the LDL receptor (LDLR), apolipoprotein B (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes 4567+1 MORE. Less commonly, mutations in other genes such as APOE and STAP1 can also contribute . FH is one of the most frequent genetic diseases, with a population prevalence estimated at about 1 in 311 people 78.
Genetic Complexity and Polygenic Factors
While mutations in LDLR, APOB, PCSK9, and LDLRAP1 account for most FH cases, many adults with hypercholesterolemia do not have mutations in these genes, suggesting a polygenic inheritance involving many other genes related to lipid metabolism 5610. Genome-wide studies have identified nearly 80 genes with variants associated with hypercholesterolemia, and over 120 additional genes with links to cholesterol traits, indicating a complex genetic landscape . In adults with primary hypercholesterolemia, about 17% have an identifiable genetic cause, with only a modest overlap between clinical and genetic diagnoses .
Diagnosis and Screening
Diagnosis of familial hypercholesterolemia relies on clinical criteria, genetic testing, and family history. However, genetic testing may not detect primary mutations in 20–40% of FH cases, highlighting the need for comprehensive diagnostic approaches 68. Cascade screening—testing relatives of affected individuals—is an effective strategy for identifying additional cases .
Treatment and Management Strategies
The main goal in managing hypercholesterolemia, especially FH, is to reduce LDL-C levels to lower the risk of ASCVD. Statins, often combined with ezetimibe, are the first-line therapy. For patients with homozygous FH or those not responding adequately, newer medications such as PCSK9 inhibitors, ANGPTL3 inhibitors, lomitapide, and LDL apheresis may be used 89. Early diagnosis and aggressive treatment are crucial for improving cardiovascular outcomes 89.
Conclusion
Hypercholesterolemia, particularly familial hypercholesterolemia, is a common and serious condition that significantly increases the risk of heart disease. Its genetic basis is complex, involving both monogenic and polygenic factors. Early identification, comprehensive screening, and effective lipid-lowering therapies are essential for reducing the burden of cardiovascular disease associated with high cholesterol 1345+5 MORE.
Sources and full results
Most relevant research papers on this topic